A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...
The Nigerian National Petroleum Corporation (NNPC) on Tuesday dismissed mounting insinuation of possible scarcity of petroleum products following ongoing disagreement between the Federal Government and members of the Petroleum and Natural Gas Senior Staff Association (PENGASSAN) on the implementation of the Integrated Payroll and Personnel Information System (IPPIS). Dr. Kennie Obateru, Group General Manager, Group Public Affairs Division of the Corporation, quoted Mallam Mele Kyari as saying, in a release, that the industrial action embarked upon by PENGASSAN would not lead to scarcity of petroleum products as all fuel stations and petrol depots in the country have enough stock of products to service consumers and are open for business. While expressing hope that the industrial dispute wo...